These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12234233)

  • 1. New evidence for stroke prevention: scientific review.
    Straus SE; Majumdar SR; McAlister FA
    JAMA; 2002 Sep; 288(11):1388-95. PubMed ID: 12234233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy?
    Johnson P; Rosewell M; James MA
    Cerebrovasc Dis; 2007; 23(2-3):156-61. PubMed ID: 17124397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of ischaemic stroke.
    Gubitz G; Sandercock P
    BMJ; 2000 Dec; 321(7274):1455-9. PubMed ID: 11110741
    [No Abstract]   [Full Text] [Related]  

  • 4. A benefit-risk assessment of agents used in the secondary prevention of stroke.
    MacWalter RS; Shirley CP
    Drug Saf; 2002; 25(13):943-63. PubMed ID: 12381215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antithrombotic therapy in patients with first-ever stroke and known non-rheumatic atrial fibrillation].
    Gandjour J; Zeindler J; Georgiadis D; Baumgartner RW
    Praxis (Bern 1994); 2005 Jan; 94(4):97-104. PubMed ID: 15732803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation.
    Yu HC; Tsai YF; Chen MC; Yeh CH
    Int J Stroke; 2012 Feb; 7(2):112-7. PubMed ID: 22103748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet therapy and anticoagulation in patients with hypertension.
    Griffin G
    Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke prevention: what's new?
    Gerraty RP
    Intern Med J; 2003 Apr; 33(4):177-81. PubMed ID: 12680984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet agents and anticoagulants for hypertension.
    Lip GY; Felmeden DC
    Cochrane Database Syst Rev; 2004; (3):CD003186. PubMed ID: 15266473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New evidence for stroke prevention: clinical applications.
    Straus SE; Majumdar SR; McAlister FA
    JAMA; 2002 Sep; 288(11):1396-8. PubMed ID: 12234234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic drugs for carotid artery dissection.
    Lyrer P; Engelter S
    Cochrane Database Syst Rev; 2000; (4):CD000255. PubMed ID: 11034680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data.
    Hughes M; Lip GY;
    Thromb Haemost; 2008 Feb; 99(2):295-304. PubMed ID: 18278178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simplified approach to the management of non-ST-segment elevation acute coronary syndromes.
    Gluckman TJ; Sachdev M; Schulman SP; Blumenthal RS
    JAMA; 2005 Jan; 293(3):349-57. PubMed ID: 15657328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
    Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP
    Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic therapy in carotid artery stenosis: an update.
    Paciaroni M; Bogousslavsky J
    Eur Neurol; 2015; 73(1-2):51-6. PubMed ID: 25402664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke prevention in the high-risk patient.
    Spence JD
    Expert Opin Pharmacother; 2007 Aug; 8(12):1851-9. PubMed ID: 17696788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
    Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.